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Abstract  1 
Objective: To evaluate the long term risk of further gynaecological surgery and cancer in women with 2 
endometriosis 3 
Design: Cohort study 4 
Setting: Scotland 5 
Participants: 281,937 women with nearly 5 million person years (4,923,628) of follow up from 1981 to 6 
2010   7 
Methods: In this national population based study we compared 17,834 women with a new surgical 8 
diagnosis of endometriosis with 83,303 women with no evidence of endometriosis at laparoscopy, 9 
162,966 women who underwent laparoscopic sterilisation and 17,834 age-matched women from the 10 
general population. Cox proportional hazards regression was used to calculate crude and adjusted 11 
Hazards ratios with 95% Confidence Intervals.  12 
Main outcome measures: Risk of further gynaecological surgery, number and type of repeat surgery 13 
and time to repeat surgery from the diagnosis of endometriosis. Cancer outcomes included 14 
subsequent risk of all cancer, gynaecological and non – gynaecological cancers. 15 
Results: Women with endometriosis had a significantly higher risk of further surgery when compared 16 
with women with no evidence of endometriosis at laparoscopy (HR 1.69, 95% CI 1.65-1.73), women 17 
who had undergone laparoscopic sterilisation (HR 3.30, 95% CI 3.23-3.37) and age-matched women 18 
from the general population (HR 5.95, 95% CI 5.71-6.20). They also have an increased risk of ovarian 19 
cancer when compared with general population counterparts (HR 1.77, 95% CI 1.08-2.89) or those 20 
with laparoscopic sterilisation (HR 1.75, 95% CI 1.26-2.45).  21 
 3 
 
Conclusion: Women with surgically diagnosed endometriosis face an increased risk of multiple 22 
surgery. They have a higher chance of developing ovarian cancer in comparison with the general 23 
population and women with laparoscopic sterilisation.  24 
Key words: Endometriosis, recurrent surgery, hysterectomy, cancer 25 
 26 
Tweetable abstract: Women with endometriosis face an increased risk of recurrent surgery and 27 
developing ovarian cancer. 28 
29 
 4 
 
Introduction 30 
Endometriosis is a chronic gynaecological condition which affects 2-10% of women of reproductive 31 
age and 30-50% of women with pelvic pain and infertility.(1) It is associated with impaired quality of 32 
life and constitutes a significant socioeconomic burden.(2) (3) The recurrence of pain is common after 33 
both medical and surgical treatment of endometriosis with reported rates varying from 30% to 50% 34 
at five years.(4) Surgery remains the mainstay for the diagnosis and treatment of endometriosis. 35 
Women often undergo multiple operations in an attempt to alleviate the symptoms of pain. 36 
Hysterectomy with removal of both ovaries is a recognised surgical option when alternative 37 
treatments have failed and fertility is no longer a priority. Studies on recurrence after treatment for 38 
endometriosis (5-9) have predominantly focussed on short to medium term outcomes and not 39 
reported on the risk or nature of further surgery. Till date there have been no studies on large national 40 
cohorts with adequate length of follow up to evaluate the risk of future surgery after the diagnosis of 41 
endometriosis.  42 
Apart from the symptoms of pain and infertility, another area of concern is a potential link between 43 
endometriosis and some cancers. The association between endometriosis and ovarian cancer appears 44 
to be the most consistent, though findings regarding other gynaecological and non-gynaecological 45 
cancers are conflicting.(10-12) The existing literature is not without limitations. A vast majority of 46 
studies relied on a self-reported diagnosis of endometriosis (13-17) or focussed on cancer risks in 47 
specific subgroups such as infertile (18-20) or postmenopausal women. (14) 48 
The natural history of endometriosis is poorly understood. An improved understanding of the long-49 
term sequelae of endometriosis is needed to allow better counselling of women, inform healthcare 50 
professionals and assist with health services planning. We therefore conducted a study to explore the 51 
impact of endometriosis on the risk of recurrent surgery and subsequent development of cancer. 52 
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Material and Methods 53 
A cohort study using Scotland wide anonymised linked data from 1981 to 2010 was conducted. All 54 
women with a new diagnosis of endometriosis (ICD 9 and 10 codes of 617 and N80 respectively) 55 
between 1981 and 2009 confirmed by either a laparoscopy or laparotomy comprised our exposed 56 
cohort. The current definition and criteria for diagnosis of endometriosis(1) means that the control 57 
group can only be reliably identified by a negative laparoscopy. This makes selection of an ideal 58 
population based unexposed cohort challenging as it is not possible to subject healthy asymptomatic 59 
women to an invasive surgical procedure. In the absence of an ideal comparison group, three 60 
unexposed cohorts were selected. The first unexposed cohort (A) consisted of women who did not 61 
have any evidence of endometriosis at a diagnostic laparoscopy during the same time period. These 62 
women had a diagnostic laparoscopy for the investigation of either pelvic pain or infertility or both. 63 
Women undergoing laparoscopic sterilisation between 1981 and 2009 constituted the second 64 
unexposed cohort (B). The third unexposed cohort (C) was derived from the general population in a 65 
1:1 ratio and included a random sample of women matched to the endometriosis cohort by the year 66 
of birth and the year of entry into the study. All women were followed up to explore long term risks 67 
of future gynaecological surgery or development of cancer up till December 2010. Women found to 68 
have cancer at the time of index surgical procedure or those with a symptom based diagnosis of 69 
endometriosis in the absence of surgical confirmation were excluded from the analysis. 70 
The date of diagnosis of endometriosis (laparoscopy or laparotomy) or the date of negative 71 
laparoscopy or laparoscopic sterilisation was used as the index date (starting point for follow up time) 72 
to estimate the future risk of gynaecological surgery or cancer. For the matched general population 73 
group, the date of diagnosis of endometriosis was used as the index date for each matched participant. 74 
Data for this study were extracted from the Scottish Morbidity Records database held by the 75 
Information Services Division (ISD) of the National Health Services Scotland. Clinical and demographic 76 
data on all in-patient and day case activity from hospitals across the whole of Scotland are routinely 77 
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collected and stored as Scottish Morbidity Records (SMR01). Diagnoses are recorded using the 78 
International Classification of Diseases (ICD) 9 and 10 codes and operations are recorded using the 79 
Classification for Surgical Operations and Procedures (OPCS) codes. ISD also holds the Community 80 
Health Index (CHI) register which is a population register of all individuals registered with a general 81 
practice in Scotland. It is used for healthcare purposes and screening programmes. National Data 82 
Standards are employed to ensure that healthcare data stored by ISD is of high quality. The data are 83 
collected throughout Scotland according to the same classifications and rules and interchanged 84 
between systems consistently, robustly and securely. The SMR register is subject to regular quality 85 
checks.  For over 20 years now and throughout this time the accuracy rate of Main Condition and Main 86 
Operation/Procedure has remained relatively stable at around 88% and 94% respectively. Further 87 
information can be accessed from http://www.isdscotland.org.  88 
Women with endometriosis, unexposed cohort A (negative laparoscopy) and unexposed cohort B 89 
(laparoscopic sterilisation) were identified from the hospital discharge database (SMR01). Women in 90 
the unexposed cohort C (general population) were obtained from the CHI register. Baseline 91 
information on age and socio-demographic characteristics was extracted for all study participants. 92 
Social class was recorded using Carstairs deprivation scale by ISD, where Class V represents the most 93 
deprived category.(21) Data on variables such as parity, smoking status, menstrual factors (age at 94 
menarche, duration and length of menstrual cycle), use of hormonal contraception, body mass index 95 
(BMI), family history and ethnicity, site and stage of endometriosis were either not available or largely 96 
missing. Prescription data were only available for the last two years (2009-2010) in our 30-year long 97 
study. 98 
Records from the hospital discharge database (SMR01) were linked internally and to the CHI 99 
population register to evaluate future gynaecological surgery outcomes and to the Scottish Cancer 100 
Registry to determine cancer outcomes in women from the exposed and unexposed groups. Data were 101 
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also linked to the General Registry of Births and Deaths in Scotland to identify those women who died 102 
in the follow up time period.  The data linkage process is illustrated in Figure 1.  103 
The long term gynaecological outcomes evaluated were the number and type of repeat gynaecological 104 
surgical procedures, time to first repeat surgery and time to hysterectomy from the diagnosis of 105 
endometriosis. Gynaecological operations were subdivided into 11 categories as per OPCS 106 
classification (Appendix S1). The surgical categories evaluated included repeat diagnostic laparoscopy, 107 
laparoscopic operations to peritoneum, ovarian surgery, excision of adnexa (unilateral or bilateral), 108 
hysterectomy, adhesiolysis, hysteroscopic procedures (including endometrial ablations), pelvic organ 109 
prolapse surgery, cystoscopy, and urinary incontinence surgery. All remaining gynaecological 110 
procedures, not included within the above ten categories were classed as ‘other gynaecological 111 
surgery’. 112 
The cancer outcomes explored were the site of cancer and time to first primary cancer.  The site of 113 
cancer was defined as per International Classification of Disease (ICD) codes (Appendix S2).  The 114 
cancers were classified as gynaecological and non-gynaecological cancers. Amongst the non-115 
gynaecological cancers, data were extracted separately for breast and gastrointestinal cancer which 116 
may have biologically plausible links to endometriosis and are two of the most common cancers in 117 
women in Scotland.(22)  118 
SPSS version 21.0 for Windows (SPSS Inc. Chicago, IL, USA) was used for analysis of data. Descriptive 119 
statistics [frequencies and percentages; mean and standard deviation (SD); median and interquartile 120 
range (IQR) as appropriate] were used to summarise each of the baseline characteristics (age, 121 
sociodemographic status and duration of follow up), gynaecological surgery and cancer in the 122 
endometriosis and each of the unexposed groups.  123 
Univariate comparisons (Chi squared test for categorical variables, t-test for parametric distributions 124 
and the Mann-Whitney test for non-parametric distributions) between the endometriosis group and 125 
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each of unexposed groups were carried out as appropriate. Data were adjusted for age and social class 126 
to perform multivariate analysis. For the gynaecological outcomes, results were also adjusted for the 127 
year of laparoscopy to accommodate for the change in practice, laparoscopic techniques and 128 
management of endometriosis over the three decades. Generalised linear models with Poisson log 129 
link were constructed to calculate the crude and adjusted incident rate ratios (IRR)  with 95% 130 
Confidence Intervals (CI) for the number of repeat surgical procedures with an offset for the follow up 131 
period. Cox proportional hazards regression was used to examine the time to first repeat surgery, time 132 
to hysterectomy and time to development of subsequent cancer from the index date amongst the 133 
exposed and each of the unexposed cohorts. Data were presented as crude and adjusted Hazard ratios 134 
(HR) with 95% Confidence Intervals. 135 
Data checks identified that the information on social class in the unexposed cohort C was not missing 136 
at random. As nearly 70% of women from this group had no hospital contact during the follow up 137 
period, information on social class (routinely extracted from the hospital discharge database) was 138 
unavailable for these women. Adjusting for social class in the multivariate analysis for this group would 139 
bias the results as 70% of women with missing data would be excluded. Given that the general 140 
population controls were matched by the year of birth and follow up duration, only univariate analysis 141 
was performed for the gynaecological and cancer outcomes when comparing the women with 142 
endometriosis with those from the general population. 143 
Results 144 
A total of 42,092 women in Scotland were diagnosed for the first time with endometriosis between 145 
1981 and 2009, as determined by the ICD codes. Of these, only 17,834 women, who had a surgical 146 
confirmation of endometriosis at laparoscopy or laparotomy were included in our exposed cohort, 147 
with a follow up period of 238,793 person years. The unexposed cohorts A and B comprised 83,303 148 
women with a negative laparoscopy and 162,966 women who had a laparoscopic sterilisation during 149 
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the same time period with a follow up of 1,412,696 years and 3,033,703 years respectively. The 150 
general population cohort included 17,834 women with a follow up of 238,436 years. 151 
The baseline characteristics of the women with endometriosis and the unexposed cohorts are shown 152 
in Table 1. Women with endometriosis were significantly older [mean age (SD) of 32.1 (7.3) years] 153 
than those who had no evidence of endometriosis at a diagnostic laparoscopy [30.8 (8.5) years] but 154 
younger than the laparoscopic sterilisation group [32.9 (5.50 years]. Women with endometriosis 155 
belonged to a more affluent social class compared to the other three unexposed groups. The median 156 
follow up duration for the endometriosis and the general population cohort was 13.1 years, the 157 
negative laparoscopy cohort 17.4 years and the laparoscopic sterilisation group 19.1 years 158 
respectively. 159 
Gynaecological outcomes 160 
As shown in Table 2, the incidence of subsequent gynaecological surgery was significantly higher in 161 
women with endometriosis (n = 11,052; 62%) when compared with women with no evidence of 162 
endometriosis at laparoscopy (n = 42,136; 50.6%), women who had undergone laparoscopic 163 
sterilisation (n = 58,704; 36%) and age-matched women from the general population (n = 2,907; 164 
16.3%).  The median (IQR) time for a second surgical procedure (after the initial diagnostic operation) 165 
for the endometriosis group was less than two years [1.8 (0.8, 4.6)] – which was significantly shorter 166 
than the corresponding period in women in the three unexposed groups. Half of all women with 167 
endometriosis had undergone repeat surgery within 5.5 years.  168 
Nearly 1 in 5 women with endometriosis had a subsequent hysterectomy (n = 4,049; 22.7%) which 169 
was significantly higher than the 1 in 10 risk in women who had undergone laparoscopy with no 170 
evidence of endometriosis (n = 8,825; 10.6%), laparoscopic sterilisation (n = 17,845; 11%) or 1 in 50 171 
chance in age-matched women from the general population (n = 397; 2.2%). Women with 172 
endometriosis appeared to have hysterectomy at a much younger age with a median time to 173 
hysterectomy of 2 years after diagnosis when compared to 7.4 years in the negative laparoscopy group 174 
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and 8.8 years in the laparoscopic sterilisation group following their primary surgery. The incidence of 175 
different types of gynaecological procedures in each group of women is shown in Table S1. With the 176 
exception of pelvic organ prolapse and urinary incontinence surgery, women with endometriosis were 177 
much more likely to have all other kinds of gynaecological operations.  178 
Women with endometriosis were also at a higher risk of multiple repeat surgical procedures. Table 2 179 
shows the incident rate ratios (IRR) for the number of operative procedures and the hazards ratios for 180 
time to first repeat surgery and hysterectomy in women with endometriosis. After allowing for the 181 
duration of follow up, and adjusting for age, socio-economic status and the year of initial laparoscopy, 182 
the adjusted IRR (95% CI) for the number of subsequent operations was 1.67 (1.65, 1.69), 2.74 (2.71, 183 
2.78) and 3.03 (2.95, 3.13) when compared with the unexposed groups A, B and C respectively. The 184 
risks of repeat surgery and hysterectomy were significantly increased in women with endometriosis 185 
with adjusted HRs (95% CI) of 1.69 (1.65, 1.73), 3.30 (3.23, 3.37) and 5.95 (5.71, 6.20) for repeat 186 
surgery and 3.14 (3.02, 3.26), 4.30 (4.15, 4.50) and 11.74 (10.6, 13.01) for hysterectomy when 187 
compared with women with no evidence of endometriosis at laparoscopy, women who had 188 
undergone laparoscopic sterilisation or the age-matched women from the general population 189 
respectively 190 
Cancer  191 
The proportion of women with endometriosis who developed cancer in the follow up period was 3.8% 192 
(n = 669). The corresponding proportions were 5.1% (n = 4,239), 6.3% (n = 10,202) and 3.1% (n = 555) 193 
in women with no evidence of endometriosis at laparoscopy, women who have had laparoscopic 194 
sterilisation and women from the general population respectively. In the endometriosis group, 195 
gynaecological malignancies accounted for 12.4% of all cancers and affected 0.5% of women during 196 
the follow up period. The incidence of gynaecological malignancy for the three unexposed cohorts A, 197 
B and C were 0.6%, 0.8% and 0.4% respectively. Breast cancer was by far the commonest cancer in all 198 
groups accounting for 37.5% of all malignancies and 1.4% of all women in the endometriosis group. 199 
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The distribution of various gynaecological cancers, breast and gastrointestinal cancers is shown in 200 
Table 3. 201 
On multivariate analysis, women with endometriosis were at a significantly higher risk of developing 202 
overall future cancer, ovarian cancer and breast cancer when compared to the general population 203 
cohort with an adjusted  HR (95% CI) of  1.21 (1.08, 1.35),  1.77 (1.08, 2.89) and 1.28 (1.06, 1.54) 204 
respectively as shown in Table 3. Ovarian cancer was more common in the endometriosis group when 205 
compared with women with laparoscopic sterilisation [adjusted HR (95% CI) of 1.75 (1.26, 2.45)]. 206 
There were no significant differences in the risk of any cancer, gynaecological malignancies and breast 207 
cancer when compared to the negative laparoscopy group.  208 
 209 
Discussion 210 
 211 
Principal Findings 212 
 213 
This Scottish nation-wide study revealed that women with endometriosis to be at a significantly higher 214 
risk of multiple further gynaecological surgeries, shorter interval to further surgery and subsequent 215 
hysterectomy following their initial diagnosis.  A diagnosis of endometriosis is associated with a higher 216 
risk of ovarian cancer when compared with the women from general population and those who have 217 
undergone laparoscopic sterilisation. There were no significant differences in the risk of any future 218 
cancer between women with surgically-diagnosed endometriosis and those with no evidence of 219 
endometriosis at laparoscopy.  220 
Strengths and Limitations 221 
With 281,937 women and nearly 5 million (4,923,628) person years of follow up, this is the largest 222 
study to describe the long term surgical and cancer outcomes in women with endometriosis. A major 223 
strength of the study is the use of a national population-based cohort, access to a complete high 224 
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quality national dataset,(23)  and a surgical diagnosis of endometriosis. This improves the validity and 225 
reliability of our results by minimising misclassification bias.  226 
Identifying an ideal unexposed cohort was difficult. Although not truly representative of community 227 
controls, the negative laparoscopy and laparoscopic sterilisation cohorts allowed us to reliably exclude 228 
endometriosis. The negative laparoscopy group comprises symptomatic women who were 229 
undergoing diagnostic laparoscopy for investigation of pelvic pain and/or infertility.  While more like 230 
‘community controls’, women undergoing laparoscopic sterilisation tend to be very different from 231 
those with endometriosis in terms of parity, use of hormonal contraceptives and demographic profile. 232 
An interplay of all these factors could potentially influence both the surgical and cancer outcomes. 233 
Although it is possible that endometriosis could have been missed at initial laparoscopy, it is worth 234 
noting that none of the women in the negative laparoscopy or the laparoscopic sterilisation group had 235 
a subsequent diagnosis of endometriosis in up to 30 years of follow up. The third unexposed cohort 236 
was truly population based. Any asymptomatic endometriosis however, could not be excluded. The 237 
chances of undiagnosed endometriosis in this group is likely to be very low as symptomatic women 238 
were excluded.  239 
This study is susceptible to the limitations associated with routinely collected data. Data were missing 240 
on confounders such as parity, smoking status, menstrual factors, use of hormonal contraception, 241 
body mass index, family history and ethnicity, site and stage of endometriosis and likely unknown 242 
confounders specific to the comparison groups. The findings of our study may not be generalisable to 243 
other ethnic groups as the study was conducted in Scotland where over 95% of the population is 244 
Caucasian. 245 
Interpretation of findings 246 
Whether the return of pain symptoms or the visualisation of endometriotic lesions at a subsequent 247 
surgery should be classed as a recurrence is a subject of continuing debate. We chose repeat surgery 248 
as a long-term outcome as it marks an objective event in the life of a woman. The literature is sparse 249 
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on long-term surgical outcomes in women with endometriosis and the few existing 250 
publications(24,25) have much smaller sample sizes with shorter durations of follow up. At 62%, the 251 
repeat operation rate following the initial surgical diagnosis in our study (17,834 women with a median 252 
follow up of 13.1 years) was higher compared to 51% reported by Cheong et al(24) (486 women with 253 
a mean duration of follow up of 5.4 years) and 55% after conservative surgery by Shakiba et al.(25) 254 
(120 women with follow up of 7.7 years).  In our study women with endometriosis not only had a 255 
higher rate (23%) of hysterectomy but also had this procedure at a much younger age (early to mid-256 
thirties). They also had a 1 in 5 risk of removal of one or both ovaries. Bilateral oophorectomy at the 257 
time of hysterectomy confers protection against ovarian and breast cancer but is known to be 258 
associated with an increase in risk of all-cause mortality, and cardiovascular disease.(26) It is possible 259 
that the impact of endometriosis on long term health of the women is iatrogenic and related to the 260 
hormonal and/or surgical treatment offered for endometriosis, rather than the disease alone.  261 
Our results suggest that the strength of the association between endometriosis with cancer is less 262 
pronounced than is reported in the literature. While a mildly elevated risk of overall cancer was noted 263 
when compared to women from the general population [HR (95% CI) of 1.21 (1.08, 1.35)], this 264 
association was not evident when compared to the negative laparoscopy or the sterilisation cohort. 265 
The choice of comparison group can influence the results as illustrated in our study with three 266 
different unexposed cohort. The vast majority of existing smaller studies have analysed cancer risks in 267 
specific subsets of women with endometriosis such as infertile women(18-20) and relied on a self-268 
reported diagnosis of endometriosis(14,15,17,27) which carries a high risk of ascertainment bias. The 269 
only two large population based cohort studies, with a surgical confirmation of endometriosis were 270 
by Melin et al. (28) in the Swedish (1969-2002) women and Wang et al.(29) (2000-2010) in the 271 
Taiwanese population. The risk of cancer in the Swedish study(28) was lower than our study with a 272 
standardised incident ratio (SIR) and (95% CI) of 1.01 (0.98, 1.05) for overall cancer, 1.08 (1.02, 1.13) 273 
for breast cancer and 1.37 (1.14–1.62) for ovarian cancer. The Taiwanese study(29) found a much 274 
higher risk of ovarian cancer [adjusted HR (95% CI) of 5.62 (3.46-9.14)] in women with endometriosis, 275 
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compared with both the Swedish and the Scottish cohort. The association of endometriosis with 276 
ovarian cancer has been studied most extensively. In a meta-analysis of 20 case control and 15 cohort 277 
studies, Kim et al.(30) reported a relative risk (RR) with 95% CI of (1.27; 1.21–1.31) in case –control or 278 
two-arm cohort studies and SIR (95% CI)) of (1.79; 1.27–2.53) in single arm cohort studies. The risk of 279 
ovarian cancer appears to be highest in women with ovarian endometrioma. (31)(32) Our findings 280 
corroborate the existing evidence in favour of increased risk of ovarian cancer in women with 281 
endometriosis, though the magnitude of effect is much smaller. The association of endometriosis with 282 
breast cancer remains controversial,(10,33,34) with studies reporting positive(19,28), negative(16,35) 283 
and lack of any association.(12,18,36) The findings across our three cohorts were inconsistent too. 284 
Within the same population, differences in statistical analysis can lend different risk 285 
estimates.(28,32,37)  286 
Thus, with the exception of ovarian cancer, the association of endometriosis with other cancers 287 
remains disputable.  A shared pathophysiology may explain a higher risk of ovarian cancer associated 288 
with endometriosis (38), including direct transformation from benign to malignant epithelium (39), 289 
free iron induced oxidative damage causing DNA mutations (40) and genomic instability similar to 290 
cancer cells.(41)   291 
Epidemiological studies are difficult to conduct in endometriosis population due to challenges in 292 
defining the onset of disease, a need for laparoscopy to establish the diagnosis, effect of hormonal 293 
contraception and pregnancy on the course of disease, difficulties in identifying an ideal comparison 294 
group and a lack of standardisation of research design. (42,43) There are huge variations in the 295 
diagnosis and management of endometriosis across the world, limiting extrapolation of findings of 296 
studies to other populations for health services planning. Multicentre prospective studies using 297 
standardised tools for clinical and sample data collection are required to elucidate the effect of varying 298 
phenotypes, genetic and environmental influences on symptoms of disease as well as impact on long-299 
term health.  300 
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Conclusions  301 
Women with endometriosis are at an increased risk of further surgery. Awareness of the risk of 302 
multiple surgical procedures including hysterectomy can be useful in counselling women with a new 303 
diagnosis of endometriosis and enable them to make timely reproductive choices. With regards to 304 
cancer, the findings of our study are generally reassuring.  The elevated risk of ovarian cancer persisted 305 
despite higher rates of oophorectomy in women with endometriosis. As the strength of association is 306 
low and the confounding influence of parity, use of hormonal contraceptives and other lifestyle factors 307 
cannot be excluded, these results should be interpreted with caution. Medical intervention in the form 308 
of combined contraceptive pill for prophylaxis, opportunistic salpingectomy or active surgical 309 
intervention in women with endometriomata would be recognised measures to reduce the risk of 310 
ovarian cancer.  311 
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